Table 4.

Procedural and hospital outcomes. Data are expressed as percentage (frequency) or median (IQR)

	Ticagrelor (n = 142)	Clopidogrel (n = 259)	P
Procedural outcomes (unadjusted analysis)
TIMI flow post-PCI	3 (3–3)	3 (3–3)	0.002
Procedural success (TIMI 3 and stenosis <50%)	99.0 (115/116)	89.9 (151/168)	0.001
Procedural success (TIMI 2–3 and stenosis <50%)	100.0 (116/116)	95.8 (161/168)	0.044
STR%	89 (50–100)	100 (50–100)	0.482
STR ≥ 50%	78.1 (82/105)	78.2 (122/156)	0.879
STR% ≥ 70%	60.0 (63/105)	66.7 (104/156)	0.294
Hospital outcomes (unadjusted analysis)
In-hospital all-cause death	0.7 (1)	5.4 (14)	0.024
In-hospital CV death	0.7 (1)	5.4 (14)	0.024
In-hospital non-fatal AMI	3.5 (5)	1.2 (3)	0.14
Ischaemic CVA	0.4 (1)	0.7 (1)	1.00
Total CVA (ischaemic or haemorrhagic)	0.4 (1)	0.7 (1)	1.00
Hospital MACE	4.9 (7)	6.9 (18)	0.52
Definite stent thrombosis	1.4 (2)	0.8 (2)	0.62
Final LVEF [%]	50 (40–55)	48 (40–55)	0.55
CPK peak [UI/L]	1347 (535–2590)	1376 (677–2491)	0.77
Hospital stay [days]	4 (4–6)	5 (4–6)	0.84

Italics: p value ≤0.05

TIMI thrombolysis in myocardial infarction, STR ST resolution, CV cardiovascular, AMI acute myocardial infarction, CVA cerebrovascular accidents, LVEF left ventricular ejection fraction, CPK creatine phosphokinase